Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Clinical trial NCT07541781 · RECRUITING

Trial details

NCT number: NCT07541781
Sponsor: Kailin Yang, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioblastoma Recurrent Glioma Recurrent Glioblastoma Grade 4 Malignant Glioma of Brain (Disorder)

Start date: 2026-06-11
Primary completion: 2029-06-11
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.